Description: Visioneering Technologies, Inc. is a medical device company. The Company's principal activity is the design, manufacture, sale and distribution of its NaturalVue Multifocal 1 Day (NaturalVue MF) contact lenses for adults with Presbyopia (an age-related condition resulting in difficulty seeing near objects) and children with Myopia (difficulty seeing distant objects). The Company offers NaturalVue MF contact lens. Its Multifocal contact lens provides Presbyopia patients with near, intermediate and distance vision and which is much easier for eye care professionals to fit to their patients. The Company's NaturalVue MF contact lenses are also used by eye care professionals for Myopia correction in children. The Company has a range of line extensions and products, such as NaturalVue Multifocal 1 Day contact lens power range extension; NaturalVue Sphere 1 Day contact lenses; NaturalVue Toric 1 Day contact lenses, and NaturalVue Multifocal Toric 1 Day contact lenses.
Home Page: www.vtivision.com
VTI Technical Analysis
Vanguard Star Funds
,
Phone:
800-662-7447
Officers
| Name | Title |
|---|---|
| Mr. Brian D. Lane CPA | Chief Operating & Chief Financial Officer |
| Mr. Tony Sommer Jr. | Sr. VP of Sales & Marketing |
| Dr. Kuang-Mon Tuan FAAO, Ph.D. | Chief Medical Officer |
| Dr. Richard A. Griffin | Founder & Medical Adviser |
| Ms. Layna L. Mendlinger | Global Head of Marketing |
| Ms. Leanne Ralph AAICD, ACIS, BBus | Company Sec. |
| Dr. Douglas P. Benoit OD, FAAO | Exec. Director of Professional Affairs |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.2338 |
| Price-to-Sales TTM: | 1.6952 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |